G. Simpson, A. Loebel, L. Warrington, Ruoyong Yang
{"title":"齐拉西酮和奥氮平对急性精神分裂症或分裂情感性障碍住院患者的疗效和耐受性:一项为期6周的双盲研究结果,为期6个月的双盲延续期","authors":"G. Simpson, A. Loebel, L. Warrington, Ruoyong Yang","doi":"10.1017/S1748232105000145","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":347111,"journal":{"name":"Progress in Neurotherapeutics and Neuropsychopharmacology","volume":"2018 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2006-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Efficacy and Tolerability of Ziprasidone and Olanzapine in Acutely Ill Inpatients with Schizophrenia or Schizoaffective Disorder: Results of a Double-Blind, Six-WeekStudy, with a Six-Month, Double-Blind Continuation Phase\",\"authors\":\"G. Simpson, A. Loebel, L. Warrington, Ruoyong Yang\",\"doi\":\"10.1017/S1748232105000145\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":347111,\"journal\":{\"name\":\"Progress in Neurotherapeutics and Neuropsychopharmacology\",\"volume\":\"2018 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-03-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Progress in Neurotherapeutics and Neuropsychopharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1017/S1748232105000145\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Neurotherapeutics and Neuropsychopharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/S1748232105000145","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Efficacy and Tolerability of Ziprasidone and Olanzapine in Acutely Ill Inpatients with Schizophrenia or Schizoaffective Disorder: Results of a Double-Blind, Six-WeekStudy, with a Six-Month, Double-Blind Continuation Phase